Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorAlliance Foundation Trials, LLC.
About this trial
The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, improves patient-centered outcomes, including financial worry, health-related quality of life (HRQoL), symptom burden, patient-reported cancer treatment adherence, and exploratory outcomes of overall survival, patient-reported economic burden, patient-reported support received, patient-reported financial coping strategies, and health insurance literacy.
Eligibility criteria
Qualifiers
Minimum age of 21
Understands English and/or Spanish
Has a diagnosis of advanced/metastatic cancer
Currently undergoing systemic therapy (enteral or parenteral) with non-curative intent
Disqualifiers
Under the age of 21
Does not understand English or Spanish
Has cognitive deficits that would preclude understanding of consent form and/or questionnaires
Undergoing treatment with curative intent (e.g., adjuvant chemotherapy for breast, lung, or ovarian cancer, primary curative therapy for testis cancer or lymphoma)
Trial design
Treatments tested in this trial
- Financial Hardship Screening
- Enhanced Usual Care
Treatment groups
1,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Alliance Foundation Trials, LLC.
Lead sponsor
Memorial Sloan Kettering Cancer Center
Collaborator
Source ClinicalTrials.gov